Abstract
Stroke remains the leading cause of death and disability across the globe. However, there is a dearth of effective therapy for its treatment. Over the past decade, use of nanomedicine has gained overwhelming interest for the treatment of cerebral stroke due to the constant failure of the conventional treatment. The most widely investigated nanocarriers include neuroprotective agents loaded on functionalized liposomes and polymeric nanoparticles for targeted delivery to the brain, metal oxide nanoparticles, carbon nanotubes, dendrimers, and scaffolds. This chapter will focus on the investigations undertaken hitherto on different types of nanocarriers for delivery of therapeutic agents for the treatment of stroke.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BBB:
-
Blood–brain barrier
- bFGF:
-
Basic fibroblast growth factor
- GBD:
-
Global Burden of Disease
- hEPC:
-
Human endothelial progenitor cells
- MSCs:
-
Mesenchymal stem cells
- PEG:
-
Polyethylene glycol
- PLA:
-
Poly(lactic acid)
- PLGA:
-
Poly(lactic-co-glycolic acid)
- ROS:
-
Reactive oxygen species
- SLN:
-
Solid lipid nanoparticles
- TfR:
-
Transferrin receptor
- tPA:
-
Tissue plasminogen activator
- uPA:
-
Urokinase-type plasminogen activator
- VEGF:
-
Vascular endothelial growth factor
References
Adibhatla RM, Hatcher JF (2008) Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets 7:243–253
Agulla J, Brea D, Campos F, Sobrino T, Argibay B, Al-Soufi W, Blanco M, Castillo J, Ramos-Cabrer P (2014) In vivo theranostics at the peri-infarct region in cerebral ischemia. Theranostics 4:90–105. https://doi.org/10.7150/thno.7088
Asahi M, Rammohan R, Sumii T, Wang X, Pauw RJ, Weissig V, Torchilin VP, Lo EH (2003) Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke. J Cereb Blood Flow Metab 23(8):895–899
Astrup J, Symon L, Branston NM, Lassen NA (1977) Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 8:51–57
Bell BA, Symon L, Branston NM (1985) CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. J Neurosurg 62:31–41
Campos-Martorell M, Cano-Sarabia M, Simats A, Hernández-Guillamon M, Rosell A, Maspoch D, Montaner J (2016) Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats. Int J Nanomedicine 11:3035–3048. https://doi.org/10.2147/IJN.S107292
Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341–347
Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076–1084
Chung CY, Yang JT, Kuo YC (2013) Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats. Biomaterials 34:9717–9727
Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi DW (1996) Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 3(2):129–135
Dugan LL, Turetsky DM, Du C, Lobner D, Wheeler M, Almli CR, Shen CK, Luh TY, Choi DW, Lin TS (1997) Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A 94(17):94349439
Ellis-Behnke RG, Schneider GE (2011) Peptide amphiphiles and porous biodegradable scaffolds for tissue regeneration in the brain and spinal cord. In: Biomedical Nanotechnology, Methods in molecular biology (Hurst S, vol ed), vol 726. New York, Springer, pp 259–281
Estevez AY, Pritchard S, Harper K, Aston JW, Lynch A, Lucky JJ, Ludington JS, Chatani P, Mosenthal WP, Leiter JC, Andreescu S, Erlichman JS (2011) Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med 51(6):1155–1163
Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120:439–448
Ferreira R, Fonseca MC, Santos T, Sargento-Freitas J, Tjeng R, Paiva F, Castelo-Branco M, Ferreirac LS, Bernardino L (2016) Retinoic acid-loaded polymeric nanoparticles enhance vascular regulation of neural stem cell survival and differentiation after ischaemia. Nanoscale. https://doi.org/10.1039/c5nr09077f
Fukuta T, Asai T, Oku N (2015) Development of a liposomal drug delivery system for the treatment of ischemic stroke. Drug Deliv Syst 30:309–316
Fukuta T, Asai T, Sato A, Namba M, Yanagida Y, Kikuchi T, Koide H, Shimizu K, Oku N (2016) Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil. Int J Pharm 506(1–2):129–137
Gilmore JL, Yi X, Quan L, Kabanov AV (2008) Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol 3(2):83–94
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329
Han QQ, Jin W, Xiao ZF, Huang JC, Ni HB, Kong J, Wu J, Chen B, Liang WB, Dai JW (2011) The promotion of neurological recovery in an intracerebral hemorrhage model using fibrin-binding brain derived neurotrophic factor. Biomaterials 32:3244–3252
Hatakeyama H, Hatakeyama H, Akita H, Maruyama K, Suhara T, Harashima H (2004) Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int J Pharm 281(1–2):25–33
Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, Scott PA, Selim MH, Woo D (2015) Guidelines for the management of spontaneous intracerebral hemorrhage a guideline for healthcare professionals from the American Heart Association/American Stroke Association. American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Stroke 46(7):2032–2060
Ishii T, Fukuta T, Agato Y, Oyama D, Yasuda N, Shimizu K, Kawaguchi AT, Asai T, Oku N (2013) Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced. Biochem Biophys Res Commun 430:1201–1205
Jin HJ, Zhang H, Sun ML, Zhang B-G, Zhang J-W (2013) Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo. J Thromb Thrombolysis 36:458–468
Johnson TA, Stasko NA, Matthews JL, Cascio WE, Holmuhamedov EL, Johnson CB, Schoenfisch MH (2010) Reduced ischemia/reperfusion injury via glutathione-initiated nitric-oxide releasing dendrimers. Nitric Oxide 22(1):30–36
Kakkar V, Muppu SK, Chopra K, Kaur IP (2013) Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm 85:339–345
Kamat S, Michelson A, Benoit S, Hacke W, Kaste M, Fieschi C (1996) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 334:1405–1406
Kawaguchi AT, Yamano M, Haida M, Ohba H, Kakiuchi T, Tsukada H (2017) Effect of oxygen affinity of liposome-encapsulated hemoglobin on cerebral ischemia and reperfusion as detected by positron emission tomography in nonhuman primates. Artif Organs 41:336–345. https://doi.org/10.1111/aor.12905
Krol S, Macrez R, Docagne F, Defer G, Laurent S, Rahman M, Hajipour MJ, Kehoe PG, Mahmoudi M (2013) Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. Chem Rev 113:1877–1903
Kubinova S, Sykova E (2010) Nanotechnology for treatment of stroke and spinal cord injury. Nanomedicine 5:99–108
Lin BL, Zhang JZ, Lu LJ, Mao JJ, Cao MH, Mao XH, Zhang F, Duan XH, Zheng CS, Zhang LM, Shen J (2017) Superparamagnetic iron oxide nanoparticles-complexed cationic amylose for in vivo magnetic resonance imaging tracking of transplanted stem cells in stroke. Nano 7:107. https://doi.org/10.3390/nano7050107
Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431–1568
Loscher W, Potschka H (2005) Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 76(1):22–76
Lovat V, Pantarotto D, Lagostena L, Cacciari B, Grandolfo M, Righi M, Spalluto G, Prato M, Ballerini L (2005) Carbon nanotube substrates boost neuronal electrical signaling. Nano Lett 5(6):1107–1110
Luo Z, Zhang S (2012) Designer nanomaterials using chiral selfassembling peptide systems and their emerging benefit for society. Chem Soc Rev 41(13):4736–4754
Massobrio G, Massobrio P, Martinoia S (2008) Modeling the neuron-carbon nanotube-ISFET junction to investigate the electrophysiological neuronal activity. Nano Lett 8(12):4433–4440
Matsumoto K, Sato C, Naka Y, Whitby R, Shimizu N (2010) Stimulation of neuronal neurite outgrowth using functionalized carbon nanotubes. Nanotechnology 21(11):115101
Mayer SA, Rincon F (2005) Treatment of intracerebral haemorrhage. Lancet Neurol 4:662–672
Mazzatenta A, Giugliano M, Campidelli S, Gambazzi L, Businaro L, Markram H, Prato M, Ballerini L (2007) Interfacing neurons with carbon nanotubes: electrical signal transfer and synaptic stimulation in cultured brain circuits. J Neurosci 27(26):6931–6936
Moon SU, Kim J, Bokara KK, Kim JY, Khang D, Webster TJ, Lee JE (2012) Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke. Int J Nanomedicine 7:2751–2765. https://doi.org/10.2147/IJN.S30273
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB (2015) Executive summary: heart disease and stroke statistics—2015 update a report from the American Heart Association. Circulation 131:434–441
Nance EA, Woodworth GF, Sailor KA (2012) A dense poly (ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Science Trans Med 4:149ra119
Partoazar A, Nasoohi S, Rezayat SM, Gilani K, Mehr SE, Amani A, Rahimi N, Dehpour AR (2017) Nano liposome containing cyclosporine A reduced neuroinflammationresponsesandimprovedneurologicalactivitiesincerebralischemia/reperfusion in rat. Fundam Clin Pharmacol 31:185–193. https://doi.org/10.1111/fcp.12244
Peng T, Britton GL, Kim H, Cattano D, Aronowski J, Grotta J, McPherson DD, Huang SL (2013) Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke. CNS Neurosci Ther 19(10):773–784
Sang LY-H, Liang YX, So KF, Leung GK-K, Ellis-Behnke RG, Cheung RT-F (2014) A self-assembling nanomaterial reduces acute brain injury and enhances functional recovery in a rat model of hypertensive intracerebral hemorrhage. J Nanomed Nanotechnol 5:1
Schubert D, Dargusch R, Raitano J, Chan SW (2006) Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 342(1):86–91
Takamiya M, Miyamoto Y, Yamashita T, Deguchi K, Ohta Y, Abe K (2012) Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice. Neuroscience 221:47–55
Taskin E, Ozcan K, Canacankatan N, Satar M, Yapicioglu HY, Erdogan S (2009) The effects of indomethacin on caspases, glutathione level and lipid peroxidation in the newborn rats with hypoxic-ischemic cerebral injury. Brain Res 1289:118–123
Thwaites JW, Reebye V, Mintz P, Levicar N, Habib N (2012) Cellular replacement and regenerative medicine therapies in ischemic stroke. Regen Med 7:387–395
Tiebosch IA, Crielaard BJ, Bouts MJ, Zwartbol R, Salas-Perdomo A, Lammers T, Planas AM, Storm G, Dijkhuizen RM (2012) Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats. J Neurochem 123(Suppl. 2):65–74. https://doi.org/10.1111/j.1471-4159.2012.07945
Torno MD, Kaminski MD, Xie Y, Meyers RE, Mertz CJ, Liu X, O’Brien WD Jr, Rosengart AJ (2008) Improvement of in vitro thrombolysis employing magnetically-guided microspheres. Thromb Res 121:799–811
Trounson A, McDonald C (2015) Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17:11–22
Vani JR, Mohammadi MT, Foroshani MS, Jafari M (2016) Polyhydroxylated fullerene nanoparticles attenuate brain infarction and oxidative stress in rat model of ischemic stroke. EXCLI J 15:378–390. https://doi.org/10.17179/excli2016-309
Wang Y, Tang M (2018) Dysfunction of various organelles provokes multiple cell death after quantum dot exposure. Int J Nanomedicine 13:2729–2742. https://doi.org/10.2147/IJN.S157135
Yang LC, Zhang QG, Zhou CF, Yang F, Zhang YD, Wang RM, Brann DW (2010) Extra-nuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS One 5(5):e9851
Zhang S, Gelain F, Zhao X (2005) Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol 15(5):413–420
Zhao H, Bao XJ, Wang RZ, Li GL, Gao J, Ma SH, Wei JJ, Feng M, Zhao YJ, Ma WB, Yang Y, Li YN, Kong YG (2011) Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats. Hum Gene Ther 22(2):207–215
Zheng S, Bai YY, Liu Y, Gao X, Li Y, Changyi Y, Wang Y, Chang D, Ju S, Li C (2015) Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement. Biomaterials 66:920
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Khan, S., Belgamwar, A., Yeole, P. (2019). Nanopharmaceuticals for the Improved Treatment of Cerebral Stroke. In: Rai, M., Yadav, A. (eds) Nanobiotechnology in Neurodegenerative Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-30930-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-30930-5_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30929-9
Online ISBN: 978-3-030-30930-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)